Abstract
Transforming growth factor β (TGF-β) functions as a tumor suppressor in premalignant cells but as a metastasis promoter in cancer cells. The dichotomous functions of TGF-β are proposed to be dictated by different partners of its downstream effector Smads. However, the mechanism for the contextual changes of Smad partners remained undefined. Here, we demonstrate that 14-3-3ζ destabilizes p53, a Smad partner in premalignant mammary epithelial cells, by downregulating 14-3-3σ, thus turning off TGF-β's tumor suppression function. Conversely, 14-3-3ζ stabilizes Gli2 in breast cancer cells, and Gli2 partners with Smads to activate PTHrP and promote TGF-β-induced bone metastasis. The 14-3-3ζ-driven contextual changes of Smad partners from p53 to Gli2 may serve as biomarkers and therapeutic targets of TGF-β-mediated cancer progression.
Original language | English (US) |
---|---|
Pages (from-to) | 177-192 |
Number of pages | 16 |
Journal | Cancer cell |
Volume | 27 |
Issue number | 2 |
DOIs | |
State | Published - Feb 9 2015 |
ASJC Scopus subject areas
- Oncology
- Cell Biology
- Cancer Research
MD Anderson CCSG core facilities
- Advanced Technology Genomics Core
- Biostatistics Resource Group
- Flow Cytometry and Cellular Imaging Facility
- Functional Genomics Core
- Research Animal Support Facility
- Small Animal Imaging Facility
- Tissue Biospecimen and Pathology Resource
- Cytogenetics and Cell Authentication Core
- Clinical Trials Office